Position in REPL
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$16,218,000
-$4,388,400 QoQ
Shares Held
2,120,000
0.0% QoQ
Ownership
2.53%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in REPL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Erste Asset Management GmbH holds $563,481,319 across 72 Biotechnology names. REPL ranks #7 (2.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AGIO |
Agios Pharmaceuticals, Inc.
|
2,704,900 | $91,506,767 | |
| 2 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
160,210 | $83,865,128 | |
| 3 | SRPT |
Sarepta Therapeutics, Inc.
|
2,968,945 | $64,604,243 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
57,209 | $44,201,961 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
91,958 | $41,062,925 | |
| 6 | MIRM |
Mirum Pharmaceuticals, Inc.
|
210,000 | $19,399,800 | |
| 7 | REPL |
Replimune Group, Inc.
This page
|
2,120,000 | $16,218,000 | |
| 8 | STOK |
Stoke Therapeutics, Inc.
|
446,000 | $14,521,760 |
All Filings in REPL
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $16,218,000 | 2,120,000 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $20,606,400 | 2,120,000 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $6,829,700 | 1,630,000 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $110,551 | 11,900 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $116,025 | 11,900 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $144,109 | 11,900 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $130,424 | 11,900 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $107,100 | 11,900 | Shares | Sole | 2024-11-26 | |
| 2024-03-31 | $97,223 | 11,900 | Shares | Sole | 2024-11-26 | |
| 2023-12-31 | $100,317 | 11,900 | Shares | Sole | 2024-11-26 | |
| 2023-09-30 | $203,609 | 11,900 | Shares | Sole | 2024-11-26 | |
| 2023-06-30 | $276,318 | 11,900 | Shares | Sole | 2024-11-26 | |
| 2023-03-31 | $210,154 | 11,900 | Shares | Sole | 2024-11-26 | |
| 2022-12-31 | $323,680 | 11,900 | Shares | Sole | 2024-11-26 | |
| 2022-09-30 | $205,513 | 11,900 | Shares | Sole | 2024-11-26 | |
| 2022-06-30 | $208,012 | 11,900 | Shares | Sole | 2024-11-26 | |
| 2022-03-31 | $202,062 | 11,900 | Shares | Sole | 2024-11-25 | |
| 2021-12-31 | $322,490 | 11,900 | Shares | Sole | 2024-11-25 | |
| 2021-09-30 | $352,716 | 11,900 | Shares | Sole | 2024-11-25 | |
| 2021-06-30 | $457,198 | 11,900 | Shares | Sole | 2024-11-25 | |
| 2021-03-31 | $363,069 | 11,900 | Shares | Sole | 2024-11-25 | |
| 2020-12-31 | $453,985 | 11,900 | Shares | Sole | 2024-11-25 | |
| No filing history on record for this holder in this stock. | ||||||